Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications
Source abstract
Abstract
The chitosan-coated magnetic nanoparticles (CS MNPs) were in situ synthesized by cross-linking method. In this method; during the adsorption of cationic chitosan molecules onto the surface of anionic magnetic nanoparticles (MNPs) with electrostatic interactions, tripolyphosphate (TPP) is added for ionic cross-linking of the chitosan molecules with each other. The characterization of synthesized nanoparticles was performed by X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS/ESCA), Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), dynamic light scattering (DLS), thermal gravimetric analysis (TGA), and vibrating sample magnetometry (VSM) analyses. The XRD and XPS analyses proved that the synthesized iron oxide was magnetite (Fe3O4). The layer of chitosan on the magnetite surface was confirmed by FTIR. TEM results demonstrated a spherical morphology. In the synthesis, at higher NH4OH concentrations, smaller sized nanoparticles were obtained. The average diameters were generally between 2 and 8 nm for CS MNPs in TEM and between 58 and 103 nm in DLS. The average diameters of bare MNPs were found as around 18 nm both in TEM and DLS. TGA results indicated that the chitosan content of CS MNPs were between 15 and 23 % by weight. Bare and CS MNPs were superparamagnetic. These nanoparticles were found non-cytotoxic on cancer cell lines (SiHa, HeLa). The synthesized MNPs have many potential applications in biomedicine including targeted drug delivery, magnetic resonance imaging (MRI), and magnetic hyperthermia.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Magnetic Properties and Synthesis of Ferrites
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100(1):5–2810.1016/j.jconrel.2004.08.010 ↗
2. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303(5665):1818–182210.1126/science.1095833 ↗
3. Bhattarai SR, Kc RB, Kim SY, Sharma M, Khil MS, Hwang PH, Chung GH, Kim HY (2008) N-hexanoyl chitosan stabilized magnetic nanoparticles: implication for cellular labeling and magnetic resonance imaging. J Nanobiotechnol 6:110.1186/1477-3155-6-1 ↗
4. Bhumkar DR, Pokharkar VB (2006) Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate. AAPS PharmSci Tech 7(2):E138–E14310.1208/pt070250 ↗
5. Calvo P, Remuñan-López C, Vila-Jato JL, Alonso MJ (1997) Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 14(10):1431–143610.1023/A:1012128907225 ↗
6. Coates J (2000) Encyclopedia of analytical chemistry. In: Meyers RA (ed) Interpretation of infrared spectra, a practical approach. Wiley, Chichester, pp 10815–10837
7. Corot C, Robert P, Idee JM, Port M (2006) Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58:1471–150410.1016/j.addr.2006.09.013 ↗
8. Daou TJ, Pourroy G, Bégin-Colin S, Grenèche JM, Ulhaq-Bouillet C, Legaré P, Bernhardt P, Leuvrey C, Rogez G (2006) Hydrothermal synthesis of monodisperse magnetite nanoparticles. Chem Mater 18:4399–440410.1021/cm060805r ↗
9. Das M, Mishra D, Maiti TK, Basak A, Pramanik P (2008) Bio-functionalization of magnetite nanoparticles using an aminophosphonic acid coupling agent: new, ultradispersed, iron-oxide folate nanoconjugates for cancer-specific targeting. Nanotechnology 19(41):41510110.1088/0957-4484/19/41/415101 ↗
10. Denkbas EB, Kilicay E, Birlikseven C, Ozturk E (2002) Magnetic chitosan microspheres: preparation and characterization. React Funct Polym 50:225–23210.1016/S1381-5148(01)00115-8 ↗
11. Dung DTK, Hai1 TH, Phuc LH, Long BD, Vinh LK, Truc PN (2009) Preparation and characterization of magnetic nanoparticles with chitosan coating, APCTP–ASEAN Workshop on Advanced Materials Science and Nanotechnology (AMSN08) IOP Publishing Journal of Physics: Conference Series 187, 01203610.1088/1742-6596/187/1/011001 ↗
12. Florence AT, Hillery AM, Hussain N, Jani PU (1995) Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Control Release 36:39–4610.1016/0168-3659(95)00059-H ↗
13. Gupta AK, Wells S (2004) Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nano Biosci 3:66–7310.1109/TNB.2003.820277 ↗
14. Hritcu D, Popa MI, Popa N, Badescu V, Balan V (2009) Preparation and characterization of magnetic chitosan nanospheres. Turk J Chem 33:785–796
15. Hu M, Li Y, Decker EA, Xiao H, McClements DJ (2010) Influence of tripolyphosphate cross-linking on the physical stability and lipase digestibility of chitosan-coated lipid droplets. J Agric Food Chem 58:1283–128910.1021/jf903270y ↗
16. Kavaz D, Odabas S, Guven E, Demirbilek M, Denkbas EB (2010) Bleomycin loaded magnetic chitosan nanoparticles as multifunctional nanocarriers. J Bioact Comp Poly 25:305–31810.1177/0883911509360735 ↗
17. Kim EH, Lee HS, Kwak BK, Kim BK (2005) Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent. J Magn Magn Mater 289:328–33010.1016/j.jmmm.2004.11.093 ↗
18. Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV, Muller RN (2010) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–211010.1021/cr068445e ↗
19. Lefevre ME, Vanderhoff JW, Laissue JA, Joel DD (1978) Accumulation of 2-mm latex particles in mouse Peyer’s patches during chronic latex feeding. Cell Mol Life Sci 34:120–12210.1007/BF01921939 ↗
20. Li MC, Liu C, Xin M, Zhao H, Wang M, Feng Z, Sun X (2005) Preparation and characterization of acylated chitosan. Chem Res Chinese U 21(1):114–116
21. Li G, Jiang Y, Huang K, Ding P, Chen J (2008) Preparation and properties of magnetic Fe3O4–chitosan nanoparticles. J Alloy Compd 466:451–45610.1016/j.jallcom.2007.11.100 ↗
22. Liu R, Zhao Y, Huang R, Zhao Y, Zhou H (2010) Shape evolution and tunable properties of monodisperse magnetite crystals synthesized by a facile surfactant-free hydrothermal method. Eur J Inorg Chem 2010(28):4499–450510.1002/ejic.201000430 ↗
23. Lu G, Kong L, Sheng B, Wang G, Gong Y, Zhang X (2007) Degradation of covalently cross-linked carboxymethyl chitosan and its potential application for peripheral nerve regeneration. Eur Polym J 43:3807–381810.1016/j.eurpolymj.2007.06.016 ↗
24. Lubbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K et al (1996) Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56(20):4686–4693
25. Ma W, Ya F, Han M, Wang R (2007) Characteristics of equilibrium, kinetics studies for adsorption of fluoride on magnetic-chitosan particle. J Hazard Mater 143:296–30210.1016/j.jhazmat.2006.09.032 ↗
26. Maaz K, Mumtaz A, Hasanain SK, Ceylan A (2007) Synthesis and magnetic properties of cobalt ferrite (CoFe2O4) nanoparticles prepared by wet chemical route. J Magn Magn Mater 308(2):289–29510.1016/j.jmmm.2006.06.003 ↗
27. Massart R, Cabuil V (1987) Synthèse en milieu alcalin de magnétite colloïdale: contrôle du rendement et de la taille des particules. J Chim Phys 84:961–97310.1051/jcp/1987840967 ↗
28. Mornet S, Vasseur S, Grasset F, Duguet E (2004) Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 14:2161–217510.1039/b402025a ↗
29. Neuberger T, Schopf B, Hofmann H, Hofmann M, Vonrechenberg B (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293(1):483–49610.1016/j.jmmm.2005.01.064 ↗
30. Paama L, Pitkänen I, Halttunen H, Perämäki P (2003) Infrared evolved gas analysis during thermal investigation of lanthanum, europium and samarium carbonates. Thermochim Acta 403:197–20610.1016/S0040-6031(03)00038-8 ↗
31. Park JH, Saravanakumar G, Kim K, Kwon IC (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 62:28–4110.1016/j.addr.2009.10.003 ↗
32. Pison U, Welte T, Giersig M, Groneberg DA (2006) Nanomedicine for respiratory diseases. Eur J Pharmacol 533(1–3):341–35010.1016/j.ejphar.2005.12.068 ↗
33. Prabaharan M, Mano JF (2005) Chitosan-based particles as controlled drug delivery systems. Drug Deliv 12(1):41–5710.1080/10717540590889781 ↗
34. Sanders E, Ashworth CT (1961) A study of particulate intestinal absorption and hepatocellular uptake. Exp Cell Res 22:114–13710.1016/0014-4827(61)90092-1 ↗
35. Singh S, Pandey VK, Tewari RP, Agarwal V (2011) Nanoparticle based drug delivery system: advantages and applications. Ind J Sci Tech 4(3):167–16910.17485/ijst/2011/v4i3.7 ↗
36. Teng X, Black D, Watkins NJ, Gao Y, Yang H (2003) Platinum–maghemite core–shell nanoparticles using a sequential synthesis. Nano Lett 3(2):261–26410.1021/nl025918y ↗
37. Tiaboonchai W, Limpeanchob N (2007) Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int J Pharm 329:142–14910.1016/j.ijpharm.2006.08.013 ↗
38. Veiseh O, Gunn JW, Zhang M (2010) Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 62:284–30410.1016/j.addr.2009.11.002 ↗
39. Wan Y, Creber KAM, Peppley B, Bui VT (2003) Synthesis, characterization and ionic conductive properties of phosphorylated chitosan membranes. Macromol Chem Physiol 204:850–85810.1002/macp.200390056 ↗
40. Wang Y, Li B, Zhou Y, Jia D (2009) In situ mineralization of magnetite nanoparticles in chitosan hydrogel. Nanoscale Res Lett 4(9):1041–104610.1007/s11671-009-9355-1 ↗
41. Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, Muldoon LL, Neuwelt EA (2010) Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 30:15–3510.1038/jcbfm.2009.192 ↗
42. Weissleder R, Cheng H-C, Bogdanova A, Bogdanov A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 7:258–26310.1002/jmri.1880070140 ↗
43. Wu Y, Wang Y, Luo G, Dai Y (2009) In situ preparation of magnetic Fe3O4–chitosan nanoparticles for lipase immobilization by cross-linking and oxidation in aqueous solution. Bioresour Technol 100(14):3459–346410.1016/j.biortech.2009.02.018 ↗
44. Xu H, Tong N, Cui L, Lu Y, Gu H (2007) Preparation of hydrophilic magnetic nanospheres with high saturation magnetization. J Magn Magn Mater 311:125–13010.1016/j.jmmm.2006.11.173 ↗
45. Ye XR, Daraio C, Wang C, Talbot JB, Jin S (2006) Room temperature solvent-free synthesis of monodisperse magnetite nanocrystals. J Nanosci Nanotechnol 6:852–85610.1166/jnn.2006.135 ↗
46. Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie S, O’Regan RM (2006) Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol 7(8):657–66710.1016/S1470-2045(06)70793-8 ↗
47. Yuwei C, Jianlong W (2011) Preparation and characterization of magnetic chitosan nanoparticles and its application for Cu(II) removal. Chem Eng J 168:286–29210.1016/j.cej.2011.01.006 ↗
48. Zhang L, Zhu X, Sun H, Chi G, Xu J, Sun Y (2010a) Control synthesis of magnetic Fe3O4–chitosan nanoparticles under UV irradiation in aqueous system. Curr Appl Phys 10:828–83310.1016/j.cap.2009.10.002 ↗
49. Zhang XL, Niu HY, Zhang SX, Cai YQ (2010b) Preparation of a chitosan-coated C18-functionalized magnetite nanoparticle sorbent for extraction of phthalate ester compounds from environmental water samples. Anal Bioanal Chem 397:791–79810.1007/s00216-010-3592-0 ↗